Colleen Acosta

Company: Freya Biosciences

Job title: Chief Executive Officer

Seminars:

Pioneering a New Class of Microbial Immunotherapies for Women’s Health 8:30 am

Our journey from idea to topline positive clinical readouts Expanding the horizon of microbiome therapeutics to reproductive health Strategy to leverage the growing movement of both the microbiome and women’s health spaces to accelerate new therapies for patientsRead more

day: Conference Day Two

Workshop C – Market Engagement: Paving a Path to Commercially Successful Microbiome Drug Development 1:30 pm

With commercial viability being more pivotal than ever to secure the longevity of microbiome drug development, learn from biopharma, payer and research leaders throughout a platform facilitating discussion across: Evaluating Market Performance: Explore the current landscape of microbiome drugs in the market, assessing the performance of approved companies and what this means for today’s therapeutics…Read more

day: Workshop Track 3